Glenmark to launch generic version of Adderall Tablets in the US market by May 2025
Company announces bioequivalent and therapeutically equivalent version of Mixed Salts of a Single Entity Amphetamine Product…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US market
Sun Pharma’s Leqselvi has potential for rapid uptake in US alopecia areata market: GlobalData
GlobalData analyst highlights Leqselvi’s high-dose advantage and renewed market entry as key drivers for swift adoption, despite…
AGA new UC guidance will reshape market access and therapeutic competition: GlobalData
AGA’s new UC guideline to accelerate adoption of advanced therapies and reshape payer strategies, says GlobalData
Vector Consulting Group reveals strategies for pharma firms to boost agility and cost efficiency in…
Strategies to increase output by 40-70% in Operations and R&D; Reduce of lab incidents by 50-70%
Drug shortage in the US to prove beneficial for Indian pharma companies
US-focused pharma companies to sustain their revenue improvement trend in FY25 on account of heightened drug shortages in the US…
Dr Reddy’s Lab launches Treprostinil Injection in the U.S.
Will be supplied as 20 mg/20 mL, 50 mg/20 mL, 100 mg/20 mL or 200 mg/20 mL vials
Strides gets USFDA approval for Potassium Chloride for Oral Solution
Potassium Chloride Oral Solution is indicated for the treatment and prophylaxis of hypokalemia
Dr Reddy’s launch Lansoprazole DR orally disintegrating tablets in US
They are indicated for the treatment of duodenal ulcers, gastric ulcers, GERD, erosive esophagitis and Zollinger-Ellison syndrome
Dr Reddy’s Laboratories launches Febuxostat Tablets in US
They are used to treat gout, which is associated with an excess of a chemical called uric acid (urate) in the body
Dr Reddy’s launches Succinylcholine Chloride Injection in US
It is a sterile, nonpyrogenic solution to be used as an ultra-short acting, depolarizing, skeletal muscle relaxant